Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $571.81 million. The enterprise value is $469.51 million.

Market Cap	571.81M
Enterprise Value	469.51M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TRVI has 101.74 million shares outstanding. The number of shares has increased by 7.29% in one year.

Current Share Class	101.74M
Shares Outstanding	101.74M
Shares Change (YoY)	+7.29%
Shares Change (QoQ)	+10.94%
Owned by Insiders (%)	0.82%
Owned by Institutions (%)	55.98%
Float	96.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.10
P/TBV Ratio	5.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.38, with a Debt / Equity ratio of 0.01.

Current Ratio	15.38
Quick Ratio	15.11
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17,029.33

Financial Efficiency

Return on equity (ROE) is -55.12% and return on invested capital (ROIC) is -36.70%.

Return on Equity (ROE)	-55.12%
Return on Assets (ROA)	-34.41%
Return on Invested Capital (ROIC)	-36.70%
Return on Capital Employed (ROCE)	-51.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.82M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +112.08% in the last 52 weeks. The beta is 0.53, so TRVI's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+112.08%
50-Day Moving Average	6.32
200-Day Moving Average	4.61
Relative Strength Index (RSI)	37.96
Average Volume (20 Days)	2,626,257

Short Selling Information

The latest short interest is 7.63 million, so 7.50% of the outstanding shares have been sold short.

Short Interest	7.63M
Short Previous Month	7.02M
Short % of Shares Out	7.50%
Short % of Float	7.90%
Short Ratio (days to cover)	3.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.09M
Pretax Income	-38.78M
Net Income	-47.35M
EBITDA	-50.94M
EBIT	-51.09M
Earnings Per Share (EPS)	-$0.44

Full Income Statement

Balance Sheet

The company has $103.26 million in cash and $957,000 in debt, giving a net cash position of $102.30 million or $1.01 per share.

Cash & Cash Equivalents	103.26M
Total Debt	957,000
Net Cash	102.30M
Net Cash Per Share	$1.01
Equity (Book Value)	99.46M
Book Value Per Share	1.00
Working Capital	98.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.27 million and capital expenditures -$35,000, giving a free cash flow of -$41.30 million.

Operating Cash Flow	-41.27M
Capital Expenditures	-35,000
Free Cash Flow	-41.30M
FCF Per Share	-$0.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.29%
Shareholder Yield	-7.29%
Earnings Yield	-8.28%
FCF Yield	-7.22%

Analyst Forecast

The average price target for TRVI is $19.31, which is 243.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.31
Price Target Difference	243.59%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2